- Home
- VABK vs NVCT Comparison
VABK vs NVCT Comparison
Compare VABK & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VABK | NVCT |
|---|---|---|
| Founded | 1998 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.3M | 274.5M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VABK | NVCT |
|---|---|---|
| Price | $43.40 | $9.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 2.9K | ★ 98.5K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | ★ 12.70 | N/A |
| EPS | ★ 0.97 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $43.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $36.48 | $5.55 |
| 52 Week High | $48.58 | $13.34 |
Technical Indicators
Market Signals| Indicator | VABK | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 49.26 |
| Support Level | $37.99 | $8.08 |
| Resistance Level | $48.58 | $9.88 |
| Average True Range (ATR) | 0.75 | 0.54 |
| MACD | -0.00 | -0.15 |
| Stochastic Oscillator | 100.00 | 25.69 |
Price Performance
Historical ComparisonAbout VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company engaged in commercial and retail banking. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and other depository services. Its segments include the Bank, VNB Trust and Estate Services, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits, and offering related services to individuals, businesses, and charitable organizations.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.